{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:13:11Z","timestamp":1778191991067,"version":"3.51.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54NS115052"],"award-info":[{"award-number":["U54NS115052"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Leukodystrophies are a clinically and genetically heterogeneous group of diseases characterized by white matter abnormalities on brain magnetic resonance imaging. Clinical, biochemical, molecular, and\/or neuroimaging findings collectively support the diagnosis confirmation. The heterogeneous and overlapping clinical presentations of different leukodystrophies and non-diagnostic molecular testing pose a significant challenge to establishing a definitive diagnosis in these rare diseases. The Myelin Disorders Biorepository Project is an observational research program that aims to establish new tests to diagnose leukodystrophies and describe the natural history of these disorders. Ensuring an accurate diagnosis is critical to the goals of this project, and this paper aims to describe the rigorous diagnostic review and confirmation process which was developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We present a diagnosis review process that contributes to an accurate diagnosis for participants enrolled in this study. Board-certified genetic counselors with expertise in these disorders audit medical records to carefully assess each enrolled participant\u2019s clinical, biochemical, and molecular features. A scale of diagnostic categories is assigned based on the record review, and a team of leukodystrophy physician experts consults for cases that require further characterization or clarification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This robust review process has resulted in a database of individuals with verified diagnoses that may be easily queried for inclusion in appropriate natural history studies and\/or treatment trials. This is a model framework that may be adapted and implemented by other rare disease groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04317-2","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:06:39Z","timestamp":1777374399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rigorous genetic diagnosis review in natural history studies"],"prefix":"10.1186","volume":"21","author":[{"given":"Amy","family":"Pizzino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaley","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Muirhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Dominguez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Banglorewala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie L.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Ruzhnikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Sherbini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Gavazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana","family":"Sevagamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"D\u2019Aiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeline","family":"Vanderver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"4","key":"4317_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ymgme.2014.12.434","volume":"114","author":"S Parikh","year":"2015","unstructured":"Parikh S, Bernard G, van der Leventer RJ, van Hove J, Pizzino A, et al. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab. 2015;114(4):501\u201315.","journal-title":"Mol Genet Metab"},{"key":"4317_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2020.06.005","volume":"111","author":"HE Soderholm","year":"2020","unstructured":"Soderholm HE, Chapin AB, Bayrak-Toydemir P, Bonkowsky JL. Elevated Leukodystrophy Incidence Predicted From Genomics Databases. Pediatr Neurol. 2020;111:66\u20139.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"4317_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13023-023-02719-0","volume":"18","author":"IC Hageman","year":"2023","unstructured":"Hageman IC, van Rooij I, de Blaauw I, Trajanovska M, King SK. A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance. Orphanet J Rare Dis. 2023;18(1):106.","journal-title":"Orphanet J Rare Dis"},{"key":"4317_CR4","unstructured":"Global Leukodystrophy Initiative [cited 2025. Available from: https:\/\/theglia.org\/"},{"issue":"1","key":"4317_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13023-018-0942-z","volume":"13","author":"M Garcia","year":"2018","unstructured":"Garcia M, Downs J, Russell A, Wang W. Impact of biobanks on research outcomes in rare diseases: a systematic review. Orphanet J Rare Dis. 2018;13(1):202.","journal-title":"Orphanet J Rare Dis"},{"key":"4317_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-90-481-9485-8_6","volume":"686","author":"R Richesson","year":"2010","unstructured":"Richesson R, Vehik K. Patient registries: utility, validity and inference. Adv Exp Med Biol. 2010;686:87\u2013104.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"4317_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/d41573-019-00180-y","volume":"19","author":"M Haendel","year":"2020","unstructured":"Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77\u20138.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4317_CR8","doi-asserted-by":"publisher","first-page":"108346","DOI":"10.1016\/j.ymgme.2024.108346","volume":"142","author":"IP de Barcelos","year":"2024","unstructured":"de Barcelos IP, Woidill S, Gavazzi F, Modesti NB, Sevagamoorthy A, Vanderver A, et al. Systematic analysis of genotype-phenotype variability in siblings with Aicardi Gouti\u00e8res Syndrome (AGS). Mol Genet Metab. 2024;142(1):108346.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"4317_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrneurol.2017.175","volume":"14","author":"W K\u00f6hler","year":"2018","unstructured":"K\u00f6hler W, Curiel J, Vanderver A. Adulthood leukodystrophies. Nat Rev Neurol. 2018;14(2):94\u2013105.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"4317_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1212\/01.wnl.0000343049.00540.c8","volume":"72","author":"R van der Schiffmann","year":"2009","unstructured":"van der Schiffmann R. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology. 2009;72(8):750\u20139.","journal-title":"Neurology"},{"issue":"10","key":"4317_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S1474-4422(19)30143-7","volume":"18","author":"MS n der Knaap","year":"2019","unstructured":"n der Knaap MS, Schiffmann R, Mochel F, Wolf NI. Diagnosis, prognosis, and treatment of leukodystrophies. Lancet Neurol. 2019;18(10):962\u201372.","journal-title":"Lancet Neurol"},{"key":"4317_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/B978-0-323-99209-1.00019-3","volume":"204","author":"NI Wolf","year":"2024","unstructured":"Wolf NI, van der Engelen M. MRI pattern recognition in white matter disease. Handb Clin Neurol. 2024;204:37\u201350.","journal-title":"Handb Clin Neurol"},{"key":"4317_CR13","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"issue":"2","key":"4317_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf"},{"issue":"4","key":"4317_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/WNO.0000000000001070","volume":"41","author":"AT Waldman","year":"2021","unstructured":"Waldman AT, Benson L, Sollee JR, Lavery AM, Liu GW, Green AJ, et al. Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis. J Neuroophthalmol. 2021;41(4):469\u201375.","journal-title":"J Neuroophthalmol"},{"issue":"8","key":"4317_CR16","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/ajmg.a.62248","volume":"185","author":"AL Barczykowski","year":"2021","unstructured":"Barczykowski AL, Langan TJ, Vanderver A, Jalal K, Carter RL. Death rates in the U.S. due to Leukodystrophies with pediatric forms. Am J Med Genet A. 2021;185(8):2361\u201373.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"4317_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13023-020-01659-3","volume":"16","author":"A Bley","year":"2021","unstructured":"Bley A, Denecke J, Kohlsch\u00fctter A, Sch\u00f6n G, Hischke S, Guder P, et al. The natural history of Canavan disease: 23 new cases and comparison with patients from literature. Orphanet J Rare Dis. 2021;16(1):227.","journal-title":"Orphanet J Rare Dis"},{"key":"4317_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/B978-0-12-819973-2.00018-6","volume":"182","author":"M Engelen","year":"2021","unstructured":"Engelen M, Kemp S, Eichler F. Endocrine dysfunction in adrenoleukodystrophy. Handb Clin Neurol. 2021;182:257\u201367.","journal-title":"Handb Clin Neurol"},{"key":"4317_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pediatrneurol.2021.09.012","volume":"125","author":"F Gavazzi","year":"2021","unstructured":"Gavazzi F, Adang L, Waldman A, Jan AK, Liu G, Lorch SA, et al. Reliability of the Telemedicine Application of the Gross Motor Function Measure-88 in Patients With Leukodystrophy. Pediatr Neurol. 2021;125:34\u20139.","journal-title":"Pediatr Neurol"},{"issue":"10","key":"4317_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1177\/08830738211000977","volume":"36","author":"F Gavazzi","year":"2021","unstructured":"Gavazzi F, Charsar BA, Williams C, Shults J, Alves CA, Adang L, et al. Acquisition of Developmental Milestones in Hypomyelination With Atrophy of the Basal Ganglia and Cerebellum and Other TUBB4A-Related Leukoencephalopathy. J Child Neurol. 2021;36(10):805\u201311.","journal-title":"J Child Neurol"},{"issue":"6","key":"4317_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0040-1722673","volume":"52","author":"F Gavazzi","year":"2021","unstructured":"Gavazzi F, Cross ZM, Woidill S, McMann JM, Rand EB, Takanohashi A, et al. Hepatic Involvement in Aicardi-Gouti\u00e8res Syndrome. Neuropediatrics. 2021;52(6):441\u20137.","journal-title":"Neuropediatrics"},{"key":"4317_CR22","doi-asserted-by":"publisher","first-page":"764626","DOI":"10.3389\/fped.2021.764626","volume":"9","author":"G Ghabash","year":"2021","unstructured":"Ghabash G, Wilkes J, Bonkowsky JL, National US. Patient and Transplant Data for Krabbe Disease. Front Pediatr. 2021;9:764626.","journal-title":"Front Pediatr"},{"issue":"12","key":"4317_CR23","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1038\/s41436-021-01286-8","volume":"23","author":"G Helman","year":"2021","unstructured":"Helman G, Mendes MI, Nicita F, Darbelli L, Sherbini O, Moore T, et al. Expanded phenotype of AARS1-related white matter disease. Genet Med. 2021;23(12):2352\u20139.","journal-title":"Genet Med"},{"key":"4317_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pediatrneurol.2021.04.014","volume":"121","author":"G Helman","year":"2021","unstructured":"Helman G, Zerem A, Almad A, Hacker JL, Woidill S, Sase S, et al. Further Delineation of the Clinical and Pathologic Features of HIKESHI-Related Hypomyelinating Leukodystrophy. Pediatr Neurol. 2021;121:11\u20139.","journal-title":"Pediatr Neurol"},{"issue":"10","key":"4317_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/jmedgenet-2020-107137","volume":"58","author":"A Malhotra","year":"2021","unstructured":"Malhotra A, Ziegler A, Shu L, Perrier R, Amlie-Wolf L, Wohler E, et al. De novo missense variants in LMBRD2 are associated with developmental and motor delays, brain structure abnormalities and dysmorphic features. J Med Genet. 2021;58(10):712\u20136.","journal-title":"J Med Genet"},{"issue":"10","key":"4317_CR26","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3174\/ajnr.A7250","volume":"42","author":"EJ Mallack","year":"2021","unstructured":"Mallack EJ, van de Askin G, Caruso PA, Musolino PL, Engelen M, et al. A Longitudinal Analysis of Early Lesion Growth in Presymptomatic Patients with Cerebral Adrenoleukodystrophy. AJNR Am J Neuroradiol. 2021;42(10):1904\u201311.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"4317_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jimd.12356","volume":"44","author":"EJ Mallack","year":"2021","unstructured":"Mallack EJ, Turk BR, Yan H, Price C, Demetres M, Moser AB, et al. MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines. J Inherit Metab Dis. 2021;44(3):728\u201339.","journal-title":"J Inherit Metab Dis"},{"key":"4317_CR28","doi-asserted-by":"crossref","unstructured":"Muirhead KJ, Clause AR, Schlachetzki Z, Dubbs H, Perry DL, Hagelstrom RT et al. Genome sequencing identifies three molecular diagnoses including a mosaic variant in the COL2A1 gene in an individual with Pol III-related leukodystrophy and Feingold syndrome. Cold Spring Harb Mol Case Stud. 2021;7(6).","DOI":"10.1101\/mcs.a006143"},{"key":"4317_CR29","doi-asserted-by":"publisher","first-page":"788168","DOI":"10.3389\/fneur.2021.788168","volume":"12","author":"S Papapetropoulos","year":"2021","unstructured":"Papapetropoulos S, Pontius A, Finger E, Karrenbauer V, Lynch DS, Brennan M, et al. Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development. Front Neurol. 2021;12:788168.","journal-title":"Front Neurol"},{"issue":"2","key":"4317_CR30","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1210\/clinem\/dgaa700","volume":"106","author":"F Pelletier","year":"2021","unstructured":"Pelletier F, Perrier S, Cayami FK, Mirchi A, Saikali S, Tran LT, et al. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C. J Clin Endocrinol Metab. 2021;106(2):e660\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"4317_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2020.10.012","volume":"115","author":"C Piccoli","year":"2021","unstructured":"Piccoli C, Bronner N, Gavazzi F, Dubbs H, De Simone M, De Giorgis V, et al. Late-Onset Aicardi-Gouti\u00e8res Syndrome: A Characterization of Presenting Clinical Features. Pediatr Neurol. 2021;115:1\u20136.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"4317_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/MED.0000000000000591","volume":"28","author":"J Ramirez Alcantara","year":"2021","unstructured":"Ramirez Alcantara J, Halper A. Adrenal insufficiency updates in children. Curr Opin Endocrinol Diabetes Obes. 2021;28(1):75\u201381.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"7","key":"4317_CR33","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3174\/ajnr.A7097","volume":"42","author":"SD van de Roosendaal","year":"2021","unstructured":"van de Roosendaal SD, Alves C, Blaser S, Vanderver A, Wolf NI, et al. Imaging Patterns Characterizing Mitochondrial Leukodystrophies. AJNR Am J Neuroradiol. 2021;42(7):1334\u201340.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"4317_CR34","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41467-021-22114-2","volume":"12","author":"I Weinhofer","year":"2021","unstructured":"Weinhofer I, Rommer P, Zierfuss B, Altmann P, Foiani M, Heslegrave A, et al. Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy. Nat Commun. 2021;12(1):1816.","journal-title":"Nat Commun"},{"issue":"4","key":"4317_CR35","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1212\/CON.0000000000001130","volume":"28","author":"L Adang","year":"2022","unstructured":"Adang L, Leukodystrophies. Continuum (Minneap Minn). 2022;28(4):1194\u2013216.","journal-title":"Continuum (Minneap Minn)"},{"issue":"4","key":"4317_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ymgme.2022.06.003","volume":"136","author":"LA Adang","year":"2022","unstructured":"Adang LA, Gavazzi F, D\u2019Aiello R, Isaacs D, Bronner N, Arici ZS, et al. Hematologic abnormalities in Aicardi Gouti\u00e8res Syndrome. Mol Genet Metab. 2022;136(4):324\u20139.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"4317_CR37","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3174\/ajnr.A7555","volume":"43","author":"C Alves","year":"2022","unstructured":"Alves C, Sherbini O, D\u2019Arco F, Steel D, Kurian MA, Radio FC, et al. Brain Abnormalities in Patients with Germline Variants in H3F3: Novel Imaging Findings and Neurologic Symptoms Beyond Somatic Variants and Brain Tumors. AJNR Am J Neuroradiol. 2022;43(7):1048\u201353.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"4317_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/08830738221081141","volume":"37","author":"JL Bonkowsky","year":"2022","unstructured":"Bonkowsky JL, Wilkes J. Time to Transplant in X-Linked Adrenoleukodystrophy. J Child Neurol. 2022;37(5):397\u2013400.","journal-title":"J Child Neurol"},{"issue":"4","key":"4317_CR39","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1093\/rheumatology\/keab860","volume":"61","author":"D Casas-Alba","year":"2022","unstructured":"Casas-Alba D, Darling A, Caballero E, Mensa-Vilar\u00f3 A, Bartrons J, Ant\u00f3n J, et al. Efficacy of baricitinib on chronic pericardial effusion in a patient with Aicardi-Gouti\u00e8res syndrome. Rheumatology (Oxford). 2022;61(4):e87\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"4317_CR40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/annrheumdis-2021-221814","volume":"81","author":"K Cetin Gedik","year":"2022","unstructured":"Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, et al. The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI and AGS. Ann Rheum Dis. 2022;81(5):601\u201313.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4317_CR41","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s13023-022-02518-z","volume":"17","author":"F Eichler","year":"2022","unstructured":"Eichler F, Sevin C, Barth M, Pang F, Howie K, Walz M, et al. Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy. Orphanet J Rare Dis. 2022;17(1):370.","journal-title":"Orphanet J Rare Dis"},{"issue":"21","key":"4317_CR42","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1212\/WNL.0000000000201374","volume":"99","author":"M Engelen","year":"2022","unstructured":"Engelen M, van Ballegoij WJC, Mallack EJ, Van Haren KP, K\u00f6hler W, Salsano E, et al. International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach. Neurology. 2022;99(21):940\u201351.","journal-title":"Neurology"},{"issue":"1","key":"4317_CR43","doi-asserted-by":"publisher","first-page":"e29322","DOI":"10.1002\/pbc.29322","volume":"69","author":"F Gavazzi","year":"2022","unstructured":"Gavazzi F, Fraser JL, Bloom M, Tochen L, Rhee J, Kwan M, et al. Hodgkin lymphoma in an individual with TREX1-mediated Aicardi Gouti\u00e8res syndrome. Pediatr Blood Cancer. 2022;69(1):e29322.","journal-title":"Pediatr Blood Cancer"},{"issue":"1\u20132","key":"4317_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ymgme.2022.07.009","volume":"137","author":"F Gavazzi","year":"2022","unstructured":"Gavazzi F, Pierce SR, Vithayathil J, Cunningham K, Anderson K, McCann J, et al. Psychometric outcome measures in beta-propeller protein-associated neurodegeneration (BPAN). Mol Genet Metab. 2022;137(1\u20132):26\u201332.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4317_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/08830738211027717","volume":"37","author":"G Ghabash","year":"2022","unstructured":"Ghabash G, Wilkes J, Barney BJ, Bonkowsky JL. Hospitalization Burden and Incidence of Krabbe Disease. J Child Neurol. 2022;37(1):12\u20139.","journal-title":"J Child Neurol"},{"key":"4317_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejpn.2022.10.003","volume":"41","author":"I Harting","year":"2022","unstructured":"Harting I, Garbade SF, Rosendaal SD, Mohr A, Sherbini O, Vanderver A, et al. Identification of PMD subgroups using a myelination score for PMD. Eur J Paediatr Neurol. 2022;41:71\u20139.","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"4317_CR47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/jimd.12457","volume":"45","author":"JL Keller","year":"2022","unstructured":"Keller JL, Eloyan A, Raymond GV, Fatemi A, Zackowski KM. Sensorimotor outcomes in adrenomyeloneuropathy show significant disease progression. J Inherit Metab Dis. 2022;45(2):308\u201317.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"4317_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10048-022-00683-8","volume":"23","author":"J Macintosh","year":"2022","unstructured":"Macintosh J, Derksen A, Poulin C, Braverman N, Vanderver A, Thiffault I, et al. Novel biallelic variants in NRROS associated with a lethal microgliopathy, brain calcifications, and neurodegeneration. Neurogenetics. 2022;23(2):151\u20136.","journal-title":"Neurogenetics"},{"issue":"5","key":"4317_CR49","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1212\/WNL.0000000000200571","volume":"99","author":"EJ Mallack","year":"2022","unstructured":"Mallack EJ, Van Haren KP, van de Torrey A, Engelen M, Raymond GV, et al. Presymptomatic Lesion in Childhood Cerebral Adrenoleukodystrophy: Timing and Treatment. Neurology. 2022;99(5):e512\u201320.","journal-title":"Neurology"},{"issue":"12","key":"4317_CR50","first-page":"101311","volume":"52","author":"NB Modesti","year":"2022","unstructured":"Modesti NB, Evans SH, Jaffe N, Vanderver A, Gavazzi F. Early recognition of patients with leukodystrophies. Curr Probl Pediatr Adolesc Health Care. 2022;52(12):101311.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"12","key":"4317_CR51","first-page":"101313","volume":"52","author":"G Perez","year":"2022","unstructured":"Perez G, Young L, Kravitz R, Sheehan D, Adang L, Van Haren K, et al. Pulmonological issues. Curr Probl Pediatr Adolesc Health Care. 2022;52(12):101313.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"4","key":"4317_CR52","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/acn3.51509","volume":"9","author":"A Smith Fine","year":"2022","unstructured":"Smith Fine A, Kaufman M, Goodman J, Turk B, Bastian A, Lin D, et al. Wearable sensors detect impaired gait and coordination in LBSL during remote assessments. Ann Clin Transl Neurol. 2022;9(4):468\u201377.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"4317_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/a-1739-2722","volume":"53","author":"MD Stellingwerff","year":"2022","unstructured":"Stellingwerff MD, Nulton C, Helman G, Roosendaal SD, Benko WS, Pizzino A, et al. Early-Onset Vascular Leukoencephalopathy Caused by Bi-Allelic NOTCH3 Variants. Neuropediatrics. 2022;53(2):115\u201321.","journal-title":"Neuropediatrics"},{"issue":"9","key":"4317_CR54","doi-asserted-by":"publisher","first-page":"104551","DOI":"10.1016\/j.ejmg.2022.104551","volume":"65","author":"CA Stutterd","year":"2022","unstructured":"Stutterd CA, Vanderver A, Lockhart PJ, Helman G, Pope K, Uebergang E, et al. Unclassified white matter disorders: A diagnostic journey requiring close collaboration between clinical and laboratory services. Eur J Med Genet. 2022;65(9):104551.","journal-title":"Eur J Med Genet"},{"issue":"2","key":"4317_CR55","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1212\/NXG.0000000000000657","volume":"8","author":"MS n der Knaap","year":"2022","unstructured":"n der Knaap MS, Bonkowsky JL, Vanderver A, Schiffmann R, Kr\u00e4geloh-Mann I, Bertini E, et al. Therapy Trial Design in Vanishing White Matter: An Expert Consortium Opinion. Neurol Genet. 2022;8(2):e657.","journal-title":"Neurol Genet"},{"key":"4317_CR56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.sleep.2022.02.008","volume":"91","author":"JW Winkelman","year":"2022","unstructured":"Winkelman JW, Grant NR, Molay F, Stephen CD, Sadjadi R, Eichler FS. Restless Legs Syndrome in X-linked adrenoleukodystrophy. Sleep Med. 2022;91:31\u20134.","journal-title":"Sleep Med"},{"issue":"7","key":"4317_CR57","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/acn3.51796","volume":"10","author":"M Al-Saady","year":"2023","unstructured":"Al-Saady M, Beerepoot S, Plug BC, Breur M, Galabova H, Pouwels PJW, et al. Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy. Ann Clin Transl Neurol. 2023;10(7):1146\u201359.","journal-title":"Ann Clin Transl Neurol"},{"issue":"8\u20139","key":"4317_CR58","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/08830738231188753","volume":"38","author":"F Gavazzi","year":"2023","unstructured":"Gavazzi F, Glanzman AM, Woidill S, Formanowski B, Dixit A, Isaacs D, et al. Exploration of Gross Motor Function in Aicardi-Gouti\u00e8res Syndrome. J Child Neurol. 2023;38(8\u20139):518\u201327.","journal-title":"J Child Neurol"},{"issue":"8\u20139","key":"4317_CR59","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/08830738231188159","volume":"38","author":"F Gavazzi","year":"2023","unstructured":"Gavazzi F, Patel V, Charsar B, Glanzman A, Erler J, Sevagamoorthy A, et al. Gross Motor Function in Pediatric Onset TUBB4A-Related Leukodystrophy: GMFM-88 Performance and Validation of GMFC-MLD in TUBB4A. J Child Neurol. 2023;38(8\u20139):498\u2013504.","journal-title":"J Child Neurol"},{"issue":"13\u201314","key":"4317_CR60","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1177\/08830738231210040","volume":"38","author":"J Joung","year":"2023","unstructured":"Joung J, Gallison K, Sollee JJ, Vigilante N, Cooper H, Liu GW, et al. Acquisition and Loss of Developmental Milestones and Time to Disease-Related Outcomes in Cerebral Alexander Disease. J Child Neurol. 2023;38(13\u201314):672\u20138.","journal-title":"J Child Neurol"},{"issue":"2","key":"4317_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1474-4422(22)00495-1","volume":"22","author":"W K\u00f6hler","year":"2023","unstructured":"K\u00f6hler W, Engelen M, Eichler F, Lachmann R, Fatemi A, Sampson J, et al. Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2\u20133 trial. Lancet Neurol. 2023;22(2):127\u201336.","journal-title":"Lancet Neurol"},{"issue":"10","key":"4317_CR62","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/jmg-2023-109223","volume":"60","author":"A Mirchi","year":"2023","unstructured":"Mirchi A, Guay SP, Tran LT, Wolf NI, Vanderver A, Brais B, et al. Craniofacial features of POLR3-related leukodystrophy caused by biallelic variants in POLR3A, POLR3B and POLR1C. J Med Genet. 2023;60(10):1026\u201334.","journal-title":"J Med Genet"},{"issue":"11","key":"4317_CR63","doi-asserted-by":"publisher","first-page":"e1306","DOI":"10.1210\/clinem\/dgad286","volume":"108","author":"J Ramirez Alcantara","year":"2023","unstructured":"Ramirez Alcantara J, Grant NR, Sethuram S, Nagy A, Becker C, Sahai I, et al. Early Detection of Adrenal Insufficiency: The Impact of Newborn Screening for Adrenoleukodystrophy. J Clin Endocrinol Metab. 2023;108(11):e1306\u201315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4317_CR64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12883-023-03354-9","volume":"23","author":"DH Schoenmakers","year":"2023","unstructured":"Schoenmakers DH, Leferink PS, Vanderver A, Bonkowsky JL, Kr\u00e4geloh-Mann I, Bernard G, et al. Core protocol development for phase 2\/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates. BMC Neurol. 2023;23(1):305.","journal-title":"BMC Neurol"},{"issue":"4","key":"4317_CR65","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/brain\/awac460","volume":"146","author":"S Srivastava","year":"2023","unstructured":"Srivastava S, Shaked HM, Gable K, Gupta SD, Pan X, Somashekarappa N, et al. SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia. Brain. 2023;146(4):1420\u201335.","journal-title":"Brain"},{"key":"4317_CR66","doi-asserted-by":"publisher","first-page":"104781","DOI":"10.1016\/j.ebiom.2023.104781","volume":"96","author":"I Weinhofer","year":"2023","unstructured":"Weinhofer I, Rommer P, Gleiss A, Ponleitner M, Zierfuss B, Waidhofer-S\u00f6llner P, et al. Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy. EBioMedicine. 2023;96:104781.","journal-title":"EBioMedicine"},{"key":"4317_CR67","doi-asserted-by":"crossref","unstructured":"Wong KN, Botto LD, He M, Baker PR 2nd, Vanderver AL, Bonkowsky JL. Novel SLC13A3 Variants and Cases of Acute Reversible Leukoencephalopathy and \u03b1-Ketoglutarate Accumulation and Literature Review. Neurol Genet. 2023;9(6):e200101.","DOI":"10.1212\/NXG.0000000000200101"},{"issue":"7","key":"4317_CR68","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jcyt.2024.03.487","volume":"26","author":"LA Adang","year":"2024","unstructured":"Adang LA, Bonkowsky JL, Boelens JJ, Mallack E, Ahrens-Nicklas R, Bernat JA, et al. Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States. Cytotherapy. 2024;26(7):739\u201348.","journal-title":"Cytotherapy"},{"key":"4317_CR69","doi-asserted-by":"crossref","unstructured":"Adang LA, D\u2019Aiello R, Takanohashi A, Woidill S, Gavazzi F, Behrens EM et al. Interferon signaling gene expression as a diagnostic biomarker for monogenic interferonopathies. JCI Insight. 2024.","DOI":"10.1172\/jci.insight.178456"},{"issue":"4","key":"4317_CR70","doi-asserted-by":"publisher","first-page":"108521","DOI":"10.1016\/j.ymgme.2024.108521","volume":"142","author":"LA Adang","year":"2024","unstructured":"Adang LA, Groeschel S, Grzyb C, D\u2019Aiello R, Gavazzi F, Sherbini O, et al. Developmental delay can precede neurologic regression in early onset metachromatic leukodystrophy. Mol Genet Metab. 2024;142(4):108521.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"4317_CR71","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/jimd.12688","volume":"47","author":"LA Adang","year":"2024","unstructured":"Adang LA, Mowafy S, Herbst ZM, Zhou Z, Schlotawa L, Radhakrishnan K, et al. Biochemical signatures of disease severity in multiple sulfatase deficiency. J Inherit Metab Dis. 2024;47(2):374\u201386.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"4317_CR72","doi-asserted-by":"publisher","first-page":"108453","DOI":"10.1016\/j.ymgme.2024.108453","volume":"142","author":"LA Adang","year":"2024","unstructured":"Adang LA, Sevagamoorthy A, Sherbini O, Fraser JL, Bonkowsky JL, Gavazzi F, et al. Longitudinal natural history studies based on real-world data in rare diseases: Opportunity and a novel approach. Mol Genet Metab. 2024;142(1):108453.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4317_CR73","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/pde.15437","volume":"41","author":"F Ahmed","year":"2024","unstructured":"Ahmed F, Do N, Vanderver AL, Treat JR. Dyschromatosis symmetrica hereditaria: A clue to early diagnosis of Aicardi-Gouti\u00e8res syndrome. Pediatr Dermatol. 2024;41(1):156\u20137.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"4317_CR74","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3174\/ajnr.A8220","volume":"45","author":"T Armangue","year":"2024","unstructured":"Armangue T, Whitehead MT, Tonduti D, Farina L, Tavasoli AR, Vossough A, et al. Brainstem Chipmunk Sign: A Diagnostic Imaging Clue across All Subtypes of Alexander Disease. AJNR Am J Neuroradiol. 2024;45(6):769\u201372.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4317_CR75","doi-asserted-by":"crossref","unstructured":"Ashton NJ, Di Molfetta G, Tan K, Blennow K, Zetterberg H, Messing A. Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease. Neurol Sci. 2024;45(9):4513\u20138.","DOI":"10.1007\/s10072-024-07495-8"},{"issue":"8","key":"4317_CR76","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/pan.14937","volume":"34","author":"JA Berger","year":"2024","unstructured":"Berger JA, Simpao AF, Dubow SR, McClung HA, Liu GW, Waldman AT, et al. A retrospective observational cohort study of the anesthetic management and outcomes of pediatric patients with Alexander disease undergoing lumbar puncture or magnetic resonance imaging. Paediatr Anaesth. 2024;34(8):810\u20137.","journal-title":"Paediatr Anaesth"},{"key":"4317_CR77","unstructured":"Chen Y, Dawes R, Kim HC, Stenton SL, Walker S, Ljungdahl A et al. De novo variants in the non-coding spliceosomal snRNA gene RNU4-2 are a frequent cause of syndromic neurodevelopmental disorders. medRxiv. 2024."},{"issue":"3\u20134","key":"4317_CR78","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/08830738241241786","volume":"39","author":"SV Cusack","year":"2024","unstructured":"Cusack SV, Gavazzi F, de Barcelos IP, Modesti NB, Woidill S, Formanowski B, et al. Characterization of Fine Motor and Visual Motor Skills in Aicardi-Gouti\u00e8res Syndrome. J Child Neurol. 2024;39(3\u20134):147\u201354.","journal-title":"J Child Neurol"},{"key":"4317_CR79","doi-asserted-by":"crossref","unstructured":"Fortin O, Christoffel K, Shoaib A, Venkatesan C, Cilli K, Schroeder JW et al. Characteristic Fetal Brain MRI Abnormalities in Pyruvate Dehydrogenase Complex Deficiency. medRxiv. 2024.","DOI":"10.1101\/2024.04.08.24303574"},{"key":"4317_CR80","doi-asserted-by":"crossref","unstructured":"Gavazzi F, Gonzalez CD, Arnold K, Swantkowski M, Charlton L, Modesti N et al. Nucleotide metabolism, leukodystrophies, and CNS pathology. J Inherit Metab Dis. 2024.","DOI":"10.1002\/jimd.12721"},{"issue":"1","key":"4317_CR81","doi-asserted-by":"publisher","first-page":"e209541","DOI":"10.1212\/WNL.0000000000209541","volume":"103","author":"F Gavazzi","year":"2024","unstructured":"Gavazzi F, Vaia Y, Woidill S, Formanowski B, Peixoto de Barcelos I, Sevagamoorthy A, et al. Nonverbal Cognitive Skills in Children With Aicardi Gouti\u00e8res Syndrome. Neurology. 2024;103(1):e209541.","journal-title":"Neurology"},{"issue":"3","key":"4317_CR82","first-page":"156","volume":"65","author":"JI Gold","year":"2024","unstructured":"Gold JI, Stefanatos AK, Fraser JL, Vanderver A, Cuddapah S. Enasidenib-induced hepatitis in an individual with Type II D2-hydroxyglutaric aciduria. JIMD Rep. 2024;65(3):156\u201362.","journal-title":"JIMD Rep"},{"issue":"3","key":"4317_CR83","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41380-023-02348-w","volume":"29","author":"G Goldberg","year":"2024","unstructured":"Goldberg G, Coelho L, Mo G, Adang LA, Patne M, Chen Z, et al. TREX1 is required for microglial cholesterol homeostasis and oligodendrocyte terminal differentiation in human neural assembloids. Mol Psychiatry. 2024;29(3):566\u201379.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"4317_CR84","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ana.26849","volume":"95","author":"Y Gong","year":"2024","unstructured":"Gong Y, Laheji F, Berenson A, Li Y, Moser A, Qian A, et al. Role of Basal Forebrain Neurons in Adrenomyeloneuropathy in Mice and Humans. Ann Neurol. 2024;95(3):442\u201358.","journal-title":"Ann Neurol"},{"issue":"5\u20136","key":"4317_CR85","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/08830738241246703","volume":"39","author":"M Kiefer","year":"2024","unstructured":"Kiefer M, Simione M, Eichler FS, Townsend EL. Development of an Infantile GM2 Clinical Rating Scale: Remote Assessment of Clinically Meaningful Health-Related Function. J Child Neurol. 2024;39(5\u20136):161\u201370.","journal-title":"J Child Neurol"},{"issue":"3","key":"4317_CR86","doi-asserted-by":"publisher","first-page":"108512","DOI":"10.1016\/j.ymgme.2024.108512","volume":"142","author":"J Kissell","year":"2024","unstructured":"Kissell J, Rochmann C, Minini P, Eichler F, Stephen CD, Lau H, et al. Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses. Mol Genet Metab. 2024;142(3):108512.","journal-title":"Mol Genet Metab"},{"key":"4317_CR87","doi-asserted-by":"crossref","unstructured":"Nomakuchi TT, Teferedegn EY, Li D, Muirhead KJ, Dubbs H, Leonard J et al. Utility of genome sequencing in exome-negative pediatric patients with neurodevelopmental phenotypes. Am J Med Genet A. 2024:e63817.","DOI":"10.1002\/ajmg.a.63817"},{"issue":"2","key":"4317_CR88","doi-asserted-by":"publisher","first-page":"108489","DOI":"10.1016\/j.ymgme.2024.108489","volume":"142","author":"C Posern","year":"2024","unstructured":"Posern C, Dreyer B, Maier SL, Eichler F, Gelb MH, Santer R, et al. Quantification of N-acetyl-l-aspartate in dried blood spots: A simple and fast LC-MS\/MS neonatal screening method for the diagnosis of Canavan disease. Mol Genet Metab. 2024;142(2):108489.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"4317_CR89","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.ajhg.2024.05.006","volume":"111","author":"E Thorpe","year":"2024","unstructured":"Thorpe E, Williams T, Shaw C, Chekalin E, Ortega J, Robinson K, et al. The impact of clinical genome sequencing in a global population with suspected rare genetic disease. Am J Hum Genet. 2024;111(7):1271\u201381.","journal-title":"Am J Hum Genet"},{"key":"4317_CR90","unstructured":"FDA. Rare Diseases: Natural History Studies for Drug Development: Draft Guidance for Industry. In: Administration UFaD, editor.; 2019."},{"issue":"Suppl 2","key":"4317_CR91","first-page":"S38","volume":"62","author":"J Liu","year":"2022","unstructured":"Liu J, Barrett JS, Leonardi ET, Lee L, Roychoudhury S, Chen Y, et al. Natural History and Real-World Data in Rare Diseases: Applications, Limitations, and Future Perspectives. J Clin Pharmacol. 2022;62(Suppl 2):S38\u201355.","journal-title":"J Clin Pharmacol"},{"key":"4317_CR92","doi-asserted-by":"publisher","first-page":"e2417","DOI":"10.1136\/bmj.e2417","volume":"344","author":"CM Taylor","year":"2012","unstructured":"Taylor CM, Karet Frankl FE. Developing a strategy for the management of rare diseases. BMJ. 2012;344:e2417.","journal-title":"BMJ"},{"issue":"10322","key":"4317_CR93","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","volume":"399","author":"F Fumagalli","year":"2022","unstructured":"Fumagalli F, Calbi V, Natali Sora MG, Sessa M, Baldoli C, Rancoita PMV, et al. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access. Lancet. 2022;399(10322):372\u201383.","journal-title":"Lancet"},{"key":"4317_CR94","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejpn.2024.03.003","volume":"49","author":"L Laugwitz","year":"2024","unstructured":"Laugwitz L, Schoenmakers DH, Adang LA, Beck-Woedl S, Bergner C, Bernard G, et al. Newborn screening in metachromatic leukodystrophy - European consensus-based recommendations on clinical management. Eur J Paediatr Neurol. 2024;49:141\u201354.","journal-title":"Eur J Paediatr Neurol"},{"issue":"14","key":"4317_CR95","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJMoa2400442","volume":"391","author":"F Eichler","year":"2024","unstructured":"Eichler F, Duncan CN, Musolino PL, Lund TC, Gupta AO, De Oliveira S, et al. Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy. N Engl J Med. 2024;391(14):1302\u201312.","journal-title":"N Engl J Med"},{"issue":"10","key":"4317_CR96","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1093\/brain\/awae169","volume":"147","author":"M Golse","year":"2024","unstructured":"Golse M, Weinhofer I, Blanco B, Barbier M, Yazbeck E, Huiban C, et al. Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy. Brain. 2024;147(10):3344\u201351.","journal-title":"Brain"},{"issue":"1","key":"4317_CR97","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s43856-025-00734-9","volume":"5","author":"M Presa","year":"2025","unstructured":"Presa M, Bailey RM, Ray S, Bailey L, Tata S, Murphy T, et al. Preclinical use of a clinically-relevant scAAV9\/SUMF1 vector for the treatment of multiple sulfatase deficiency. Commun Med (Lond). 2025;5(1):29.","journal-title":"Commun Med (Lond)"},{"key":"4317_CR98","doi-asserted-by":"crossref","unstructured":"DeBarber A, Kisanuki Y, Nobrega P, Himes R, Jayadev S, Bernat J et al. P142: Efficacy, safety and tolerability of chenodeoxycholic acid in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized, placebo-controlled phase 3 study*. Genet Med Open. 2024;2.","DOI":"10.1016\/j.gimo.2024.101039"},{"issue":"1","key":"4317_CR99","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12969-023-00817-8","volume":"21","author":"N Kanazawa","year":"2023","unstructured":"Kanazawa N, Ishii T, Takita Y, Nishikawa A, Nishikomori R. Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS\/CANDLE, SAVI, And AGS). Pediatr Rheumatol Online J. 2023;21(1):38.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"4317_CR100","doi-asserted-by":"publisher","first-page":"e63978","DOI":"10.1002\/ajmg.a.63978","volume":"197","author":"TF Spracklen","year":"2025","unstructured":"Spracklen TF, Akhalwaya S, Ackermann S, Uggenti C, Seabra L, Crow YJ, et al. Baricitinib Treatment in RNU7-1-Associated Aicardi-Goutieres Syndrome in a South African Child: A Case Report. Am J Med Genet A. 2025;197(5):e63978.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"4317_CR101","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"23","key":"4317_CR102","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, et al. ClinGen\u2013the Clinical Genome Resource. N Engl J Med. 2015;372(23):2235\u201342.","journal-title":"N Engl J Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04317-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04317-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04317-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:05:07Z","timestamp":1778191507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04317-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04317-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Myelin Disorders Biorepository Project (MDBP) is reviewed and approved by the Children\u2019s Hospital of Philadelphia (CHOP IRB #14-011236). All research was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AP, KA, EW, KM, JS, CD, PB, JLF, MR, JC, OS, RL, FG, AS, AVi, and RDA have no disclosures. AVa receives research support from Eli Lilly, Boehringer Ingelheim, Biogen, Immunesensor, Synaptixbio, Sanofi, Affinia, Orchard, Homology, Myrtelle, Bluebirdbio, Ionis, Illumina.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}